“Incorporation of social value and patient perspectives in the development of HTA”
Date: May 18th, 2018
Speaker: Dr. Carlos Eduardo Pinzón-Flórez, Deputy Director of Health Technology Evaluation of the Institute of Health Technology Assessment (IETS), Colombia
Theme: Presentation on the project carried out in Colombia by IETS to develop a frame of reference for the inclusion of social values and the opinions of affected patients and citizens in the evaluation of health technologies and coverage decisions.
Speaker: Victoria Hurtado Meneses and Catherine De la Puente Agurto, Ministry of Health of Chile
Theme: A methodology for Economic Evaluation (EE) transferability is proposed to inform decision makers about the cost-effectiveness of a health alternative in a timely manner. This methodology could be specially useful for countries that have limited economic resources to develop research, and could also relieve the existing rush that the authorities have when requesting this type of information.The construction of a “de novo” study continues to be the gold standard to provide valid evidence on the cost-effectiveness of a health intervention. However, there are scenarios where health technologies were evaluated in several countries and there is enough evidence of their cost-effectiveness. It is in these cases that the use of the methodology for EE transferability would be most useful, so that the response given to the decision makers is based on solid evidence and can be given in a short period of time.
“Particularities in the evaluation and incorporation of Medical Devices”
Date: October 13th, 2017
Speaker: Murilo Contó, National Consultant for Health Technology Assessment and Management PAHO / WHO
Theme: Considering the peculiarities and differences that medical devices possess in relation to other health technologies, the webinar aims to address the main aspects that must be observed when a Health Technology Assessment involves the use of a medical device or equipment, reducing uncertainty in the decision-making process.
Speaker: Augusto Afonso Guerra Jr. of the General University of Minas Gerais, from the the Federal University of Minas Gerais (UFMG) in Brazil
Theme: The aim of the webinar was to explore the importance of the origin of the data in health technology assessments. The webinar discussed the difference between randomized clinical trials (RCTs) and real-world evidence (RWE) in the use of administrative and epidemiological databases to measure effectiveness. Although RWE can be very complex, it provides an understanding of health settings which is difficult to achieve through RCTs. This RWE could serve to ensure that health systems are achieving the expected results through the incorporation of health technologies. Afonso Guerra Jr. used a case study from Brazil of Big Data in the evaluation of health technologies.